USANA Health Sciences Statistics
Share Statistics
USANA Health Sciences has 18.62M
shares outstanding. The number of shares has increased by -0.77%
in one year.
| Shares Outstanding | 18.62M |
| Shares Change (YoY) | -0.77% |
| Shares Change (QoQ) | -0.81% |
| Owned by Institutions (%) | 56.51% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 10 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 912.21K, so 4.9% of the outstanding
shares have been sold short.
| Short Interest | 912.21K |
| Short % of Shares Out | 4.9% |
| Short % of Float | 8.47% |
| Short Ratio (days to cover) | 3.68 |
Valuation Ratios
The PE ratio is 16.19 and the forward
PE ratio is 9.56.
USANA Health Sciences's PEG ratio is
-0.48.
| PE Ratio | 16.19 |
| Forward PE | 9.56 |
| PS Ratio | 0.8 |
| Forward PS | 0.5 |
| PB Ratio | 1.28 |
| P/FCF Ratio | 13.36 |
| PEG Ratio | -0.48 |
Financial Ratio HistoryEnterprise Valuation
USANA Health Sciences has an Enterprise Value (EV) of 527.64M.
| EV / Sales | 0.62 |
| EV / EBITDA | 5.34 |
| EV / EBIT | 8.65 |
| EV / FCF | 10.36 |
Financial Position
The company has a current ratio of 2,
with a Debt / Equity ratio of 0.05.
| Current Ratio | 2 |
| Quick Ratio | 1.5 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.29 |
| Debt / FCF | 0.57 |
| Interest Coverage | 236.03 |
Financial Efficiency
Return on Equity is 7.9% and Return on Invested Capital is 5.79%.
| Return on Equity | 7.9% |
| Return on Assets | 5.62% |
| Return on Invested Capital | 5.79% |
| Revenue Per Employee | $502,648.82 |
| Profits Per Employee | $24,723.53 |
| Employee Count | 1,700 |
| Asset Turnover | 1.14 |
| Inventory Turnover | 2.31 |
Taxes
| Income Tax | 34.29M |
| Effective Tax Rate | 44.91% |
Stock Price Statistics
The stock price has increased by -36.78% in the
last 52 weeks. The beta is 0.6, so USANA Health Sciences's
price volatility has been higher than the market average.
| Beta | 0.6 |
| 52-Week Price Change | -36.78% |
| 50-Day Moving Average | 27.66 |
| 200-Day Moving Average | 34.68 |
| Relative Strength Index (RSI) | 64.45 |
| Average Volume (20 Days) | 235,732 |
Income Statement
In the last 12 months, USANA Health Sciences had revenue of 854.5M
and earned 42.03M
in profits. Earnings per share was 2.2.
| Revenue | 854.5M |
| Gross Profit | 693.29M |
| Operating Income | 66.32M |
| Net Income | 42.03M |
| EBITDA | 98.86M |
| EBIT | 76.63M |
| Earnings Per Share (EPS) | 2.2 |
Full Income StatementBalance Sheet
The company has 181.77M in cash and 29.01M in
debt, giving a net cash position of 152.75M.
| Cash & Cash Equivalents | 181.77M |
| Total Debt | 29.01M |
| Net Cash | 152.75M |
| Retained Earnings | 478.94M |
| Total Assets | 746.6M |
| Working Capital | 144.01M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 60.99M
and capital expenditures -10.07M, giving a free cash flow of 50.92M.
| Operating Cash Flow | 60.99M |
| Capital Expenditures | -10.07M |
| Free Cash Flow | 50.92M |
| FCF Per Share | 2.67 |
Full Cash Flow StatementMargins
Gross margin is 81.13%, with operating and profit margins of 7.76% and 4.92%.
| Gross Margin | 81.13% |
| Operating Margin | 7.76% |
| Pretax Margin | 8.94% |
| Profit Margin | 4.92% |
| EBITDA Margin | 11.57% |
| EBIT Margin | 7.76% |
| FCF Margin | 5.96% |
